Table 2.
Routine laboratory tests in patients with severe WNV NID.
| CSF Results | ||
|---|---|---|
| Patients with elevated CSF cell count, n (%) | 23 (100%) | Reference values |
| Cells/mm3, median (range) | 197 (12–1520) | 0–5 |
| Patients with CSF mononuclear predominance, n (%) | 17 (73.9%) | |
| Mononuclear cells, % median (range) | 60 (25–98) | Mononuclear 100% |
| Proteins (g/L) mean ± SD | 1.1 ± 0.5 | 0.17–0.37 g/L |
| Glucose (mmol/L) mean ± SD | 5.0 ± 2.1 | 2.5–3.3 mmol/L |
| Bacterial cultures and PCR | Negative (100%) | |
| Hematological and biochemistry results (average ± standard deviation) | ||
| CRP (mg/L) | 44.2 ± 45.9 | <5.0 mg/L |
| White blood cell count (×109/L) | 11.17 ± 4.00 | 4.0–10.0 (×109/L) |
| Red blood cells count (×1012/L) | 4.45 ± 0.08 | 4.4–5.8 (×1012/L) |
| Hemoglobin (g/L) | 133.26 ± 19.73 | 120–180 g/L |
| Platelets (×109/L) | 155.5 ± 58.35 | 100–400 (×109/L) |
| AST (U/L) | 37.13 ± 20.90 | 11–38 U/L |
| ALT (U/L) | 34.9 ± 22.5 | 12–48 U/L |
| GGT (U/L) | 73.9 ± 84.4 | 11–55 U/L |
CSF = cerebrospinal fluid; CRP = C-reactive protein; AST = aspartate aminotransferase; ALT = alanine aminotransferase; GGT = gamma-glutamyl transferase.